MoneyWorks4Me

Venus Remedies - Quaterly Results

30 Jan 2023 Evaluate
The sales slipped to Rs. 1094.50 millions for the December 2022 quarter as against Rs. 1174.40 millions during the year-ago period.The Net Profit of the company slipped to Rs. 26.10 millions from Rs. 78.50 millions, a decline of -66.75% on QoQ basis.Operating profit for the quarter ended December 2022 decreased to 108.30 millions as compared to 153.00 millions of corresponding quarter ended December 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 1094.50 1174.40 -6.80 3891.30 4469.30 -12.93 5751.81 5146.23 11.77
Other Income 37.50 10.70 250.47 69.30 59.60 16.28 84.29 177.62 -52.54
PBIDT 108.30 153.00 -29.22 474.30 674.70 -29.70 772.50 646.25 19.54
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 127.26 -100.00
PBDT 108.30 153.00 -29.22 474.30 674.70 -29.70 772.50 753.41 2.53
Depreciation 69.70 84.00 -17.02 233.10 252.20 -7.57 325.80 342.80 -4.96
PBT 38.60 69.00 -44.06 241.20 422.50 -42.91 446.70 410.61 8.79
TAX 12.50 -9.50 -231.58 26.90 -43.19 -162.28 -43.16 -132.12 -67.33
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 26.10 78.50 -66.75 214.30 465.69 -53.98 489.86 542.73 -9.74
Equity 133.70 133.70 0.00 133.70 133.70 0.00 133.67 123.42 8.30
PBIDTM(%) 9.89 13.03 -24.05 12.19 15.10 -19.26 13.43 12.56 6.95
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1145.25
Cipla 1359.75
Lupin 2047.20
Zydus Lifesciences 1105.00
View more..